Man Group PLC 2seventy Bio, Inc. Transaction History

Man Group PLC

  • $49.7 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$2.3 - $4.96 $4.7 Million - $10.1 Million
2,043,026 New
2,043,026 $10.1 Million
Q4 2022

Feb 14, 2023
BUY
$8.57 - $17.0 $681,349 - $1.35 Million
79,504 New
79,504 $744,000
Q2 2022

Aug 15, 2022
BUY
$10.55 - $18.81 $158,250 - $282,150
15,000 New
15,000 $198,000

Others Institutions Holding TSVT

# of Institutions
27
Shares Held
8.43M
Call Options Held
91.9K
Put Options Held
0
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $189M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email